Diagnostic News and Research

RSS

New DNA test can quickly and accurately identify a range of hard-to-diagnose genetic diseases

A new DNA test, developed by researchers at the Garvan Institute of Medical Research in Sydney and collaborators from Australia, UK and Israel, has been shown to identify a range of hard-to-diagnose neurological and neuromuscular genetic diseases quicker and more-accurately than existing tests.

4 Mar 2022

Study does not find association between hematological parameters and COVID-19-related hospitalization

Researchers examine the genetic factors influencing hematological parameters in SARS-CoV-2 infection.

4 Mar 2022

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Researchers evaluate the feasibility and robustness of an optimized RT-LAMP SARS-CoV-2 detection assay across multiple resource-restricted settings.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

NEJM editorial highlights the difficulty of diagnosing heart attacks in postoperative patients

Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients, including the electrocardiogram and blood tests to detect levels of cardiac troponins, according to an editorial in the New England Journal of Medicine (NEJM) written by two UT Southwestern faculty members.

3 Mar 2022

Home blood pressure monitoring may provide the basis for accurate diagnoses of hypertension

Blood pressure measurements routinely taken at home are more likely to provide the basis for accurate diagnoses of hypertension than those taken in a clinic setting, according to a new study led by Kaiser Permanente investigators.

3 Mar 2022

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics.

From Fortis Life Sciences 3 Mar 2022

Scientists identify new biomarkers that can be used as predictive tools of deep space flight risks

An international team of scientists has found new biomarkers that can be used for diagnostic purposes and potentially as predictive tools of the risks associated with deep space flight.

2 Mar 2022

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Alzheimer's disease usually is diagnosed based on symptoms, such as when a person shows signs of memory loss and difficulty thinking.

2 Mar 2022

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Functional Movement Disorders (FMDs) are common and disabling conditions. With an increasing research interest in FMDs, including the emergence of intervention trials, it is crucial to examine research methodology and develop standardized protocols.

2 Mar 2022

Covid expert joins exodus into business, where science parlays into profits

Millions of free covid-19 rapid tests arriving in Americans' mailboxes are long-awaited vindication for Dr. Michael Mina, who, as a Harvard assistant professor, had been advocating for two years that the best way to limit covid is to identify it quickly, cheaply, and widely with rapid antigen tests so infected people know to isolate themselves.

2 Mar 2022

Aggressive brain tumor in children can be identified by analyzing cerebrospinal fluid

It may be possible to identify the presence of an aggressive brain tumor in children by studying their cerebrospinal fluid, according to new research led by Johns Hopkins Kimmel Cancer Center investigators.

2 Mar 2022

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

An new study published presents evidence that a prior history of infection with SARS-CoV-2 provides immunity that prevents reinfection for at least a year.

2 Mar 2022

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

2 Mar 2022

Government invests £260 million to support health research and life sciences manufacturing

Patients across the country are set to benefit from cutting-edge medical advances and treatments as the government invests £260 million today (Wednesday 2 March) to support research and development, as well as the manufacturing of new drugs, devices and diagnostics.

2 Mar 2022

Developmental delays related to Leigh syndrome may occur earlier than previously known

Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia have found that developmental delays associated with Leigh syndrome, the most common pediatric mitochondrial disorder, may occur earlier than previously recognized – even before metabolic stroke and regression – which could provide clinicians with an opportunity for earlier diagnosis and therapeutic interventions.

1 Mar 2022

Diagnostic News and Research

New DNA test can quickly and accurately identify a range of hard-to-diagnose genetic diseases

Study does not find association between hematological parameters and COVID-19-related hospitalization

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

COVID-19 and the life sciences; what have we learned and where are we going?

NEJM editorial highlights the difficulty of diagnosing heart attacks in postoperative patients

Home blood pressure monitoring may provide the basis for accurate diagnoses of hypertension

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

Scientists identify new biomarkers that can be used as predictive tools of deep space flight risks

Novel MRI approach can identify brain cell damage in people at early stages of Alzheimer's

Researchers propose potential fixes to develop evidence-based diagnostic criteria for FMDs

Covid expert joins exodus into business, where science parlays into profits

Aggressive brain tumor in children can be identified by analyzing cerebrospinal fluid

Durability of immunity to SARS-CoV-2 reinfection among initially unvaccinated individuals with previous SARS-CoV-2 infection

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Government invests £260 million to support health research and life sciences manufacturing

Developmental delays related to Leigh syndrome may occur earlier than previously known

Buccal cell epigenetic biomarkers may predict preterm birth

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Using AI to detect antibiotic resistance

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News